Business UpdateMay 26, 2026, 08:32 AM
Allogene to Participate in Three Upcoming Investor Conferences
AI Summary
Allogene Therapeutics, a clinical-stage biotechnology company, announced its participation in three upcoming investor conferences. The company will present at the TD Cowen 7th Annual Oncology Innovation Summit on May 26, the Jefferies Global Healthcare Conference on June 3, and the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on June 9. Webcasts of the presentations will be available on Allogene's investor relations website.
Key Highlights
- Allogene Therapeutics to participate in three investor conferences.
- TD Cowen 7th Annual Oncology Innovation Summit on May 26.
- Jefferies Global Healthcare Conference on June 3.
- H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on June 9.
- Webcasts and replays will be available on the company's website.
Price Impact
More from ALLO